Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 52 results found. Search for [ dengue ]

Results 1 to 21 of 52
Joe C Mathew
New Delhi, August 21, 2018
From an AI stand point, India is quite far behind. One of the reasons is that we don't have a robust educational system, which would give us the talent pool that can develop AI tools, says Sunil Wadhwani.

E. Kumar Sharma
New Delhi, July 23, 2018
Diagnostic tests have moved beyond identifying the ailment and are now guiding doctors on the line of treatment to follow.

Joe C Mathew
New Delhi, February 20, 2018
National Pharmaceutical Pricing Authority (NPPA) has found that over 25 percent of the bill charged by four private hospitals in the National Capital Region of Delhi on some of their patients was on drugs that were out of price control.

December 27, 2017

Joe C Mathew
New Delhi, December 18, 2017
Last week, National Pharmaceutical Pricing Authority (NPPA) broughtto the public domain the retail price and trade margin details of all themedicines and consumables that were billed by a leading pan-Indian hospitalchain while treating a dengue patient in a hospital in Gurugram

E Kumar Sharma
December 17, 2017
On Friday, the National Pharmaceutical Pricing Authority without either pronouncing Fortis guilty or absolving it of any wrong doing, just confined itself to saying: \"NPPA shall be taking necessary follow up action as per existing law and within its jurisdiction.\"

Joe C Mathew
New Delhi, December 11, 2017
The immediate provocation apparently was the action initiated by Haryana government against one of the hospitals of the leading private healthcare provider Fortis for allegedly failing to provide adequate treatment to a seven year old dengue patient.
December 8, 2017
Delhi Chief Mnister Arvind Kejriwal tweeted, \"Whereas we don't wish to interfere in day to day functioning of private hospitals, however, open loot or criminal negligence by any hospital won't be tolerated. We won't hesitate to take strongest action in such cases.\"

PB Jayakumar
New Delhi, November 2, 2017
Pune-based vaccine manufacturer Serum Institute of India has launched two more vaccines - for rotavirus causing diarrhoea and rabies - and is working on a few more from dengue to cervical cancer.

Priyadarshini Maji
New Delhi, June 21, 2017
Dengue is quite a dreaded disease, and insurance companies are offering special insurance cover to take care of the medical expenses in case it is required.

Rashmi Bansal
New Delhi, June 10, 2017
In three years, this commerce-driven city has seen a complete transformation. Here's how it happened

BT Online
New Delhi, May 31, 2017
The NGT-ban on spraying disinfectant has disabled IndiGo to take measures against bugs on their planes.

New Delhi, April 23, 2017
Do not for the BJP and put the lives of your children \"at stake\", Delhi Chief Minister Arvind Kejriwal today said, in a last-ditch effort to shore up the AAP's prospects in the municipal polls.

Tapan Singhel
Delhi, December 13, 2016
\"Insurers are trying to reduce the gap between the medical spends in the country and what is covered under health insurance\"

By Goutam Das
Delhi, November 26, 2016
What chats with cab drivers tell us about the taxi aggregation business, and India.

London, November 8, 2016
The study said more than a quarter of cases were spreadwithin the same household, while half of infections occurred in households lessthan 200 metres away, creating small clusters of the disease.

Joe C Mathew
New Delhi, October 19, 2016
India's biggest drug maker Sun Pharmaceutical Industries has tied up with Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine that targets all four types of dengue viruses that cause disease in humans.

October 6, 2016
After receiving authorization in 11 countries, Sanofi Pasteur is still awaiting for approval from the government to launch its dengue vaccine Dengvaxia in India.

E Kumar Sharma
New Delhi, October 5, 2016
Business Today checked with the Drug Controller General of India (DCGI) and the Indian regulator's view is that the marketing approval to the vaccine has still not been granted in India because the regulator is keen to know the efficacy on the Indian population.

Umesh Rao
September 27, 2016
With the advent of the nuclear family theory in metro cities our dependence on domestic help has increased, along with our inability coupled with stress. The absence of such support system even for a day disrupts our lives.

PAGES 1 OF 3  123